What Are the Symptoms of Prostate Cancer? What Should I Ask and Know About Diagnosis and Treatment?

Prostate cancer is cancer of the prostate gland, which surrounds like a ring the urethra carrying urine from the bladder out of the body. Over the last 20 years, increasing numbers have been diagnosed early and had a chance of complete treatment. This article covers prostate cancer symptoms, steps for early diagnosis and brief treatment information.
I Suspect I May Have Prostate Cancer. What Should I Ask? What Should I Know?
You should know the symptoms of prostate cancer!
Early-stage prostate cancer generally has no symptoms. Advanced disease may cause:
- Urination problems: reduced or slow flow and frequent urges, particularly in the evening,
- Blood in urine (hematuria),
- Erection problems, medically called impotence,
- Pain in the hips, back (spine), chest or elsewhere because cancer has spread to bones,
- Weakness or numbness in the legs or feet, or urinary or fecal incontinence because cancer presses on the spinal cord.
Other diseases may cause the same symptoms. Difficulty urinating, for example, may result from benign prostate enlargement rather than cancer. Nevertheless, these symptoms should prompt immediate consultation with a specialist, allowing the necessary diagnosis early and treatment to begin promptly.
Does Everyone Have the Same Chance of Developing Prostate Cancer? What Should I Ask and Know About Causes Increasing the Likelihood?
Approximately %20 of men will develop prostate cancer at some point. Only %3 of this rate poses a threat to life. As with all cancers, early diagnosis can reduce deaths from prostate cancer.
Prostate cancer can develop through both genetic and nongenetic factors. Genetic factors are hereditary and largely unmodifiable. Environmental factors varying with lifestyle, such as diet, exercise, smoking and alcohol, are nongenetic and can be changed. Different cancer types have factors increasing their likelihood, but having one or more risk factors does not mean you will develop the disease.
Hereditary or Genetic Factors in Prostate Cancer
An estimated %9 of prostate cancers may arise from hereditary predisposition genes. Genetic prostate cancer is determined by these specific genes. In an average %15 of affected men, the disease is inherited from first-degree male relatives (father or brother). Despite important progress, research continues. A mutation in BRCA2, known for its connection with breast and ovarian cancers in women, has been observed to increase prostate cancer likelihood in men.
Environmental or Nongenetic Factors in Prostate Cancer
Why some men develop prostate cancer and others do not remains unclear. Research nevertheless shows that environmental factors play a greater role than genetic factors. Although the cause is uncertain, some associated factors can be identified:
The Effect of Age in Prostate Cancer: Risk increases with advancing age, so prostate cancer can also be called a disease of old age. It is rare in men younger than 50 but common in those older than 55.
Nutrition in Prostate Cancer: Research has not found a clear link between particular foods and prostate cancer likelihood. However, a study reported on our website showed that fried foods increase risk.
Although earlier studies suggested selenium and vitamin E might reduce risk, clearer subsequent results showed that neither provides benefit.
Drugs used to treat benign prostate cancer: These are called 5-alpha-reductase inhibitors. They prevent testosterone from becoming dihydrotestosterone (DHT), the most potent male hormone in the prostate. Used for benign prostate enlargement (benign prostatic hyperplasia), they may reduce prostate cancer likelihood in high-risk men. These drugs are finasteride and dutasteride. However, they must only be used on medical advice. Individuals should not take them independently to prevent prostate cancer.
If My Prostate Cancer Risk Is High, What Should I Ask and Know About Early Diagnosis? Can a Prostate Cancer Checkup Be Performed?
You should ask your physician whether prostate cancer screening tests are necessary for you.
Prostate cancer can be diagnosed early by measuring prostate-specific antigen (PSA) in blood. Another early diagnostic method is examination through the anus with a finger (digital rectal examination). If either test produces abnormal findings, further tests may be needed to investigate cancer. Cancer detected following PSA testing or digital rectal examination has probably been found early, when it can be treated.
Early Diagnosis of Prostate Cancer Is Possible!
Screening tests can help detect many prostate cancers early. However, neither PSA testing nor digital rectal examination provides %100 certainty. False positives can lead to unnecessary prostate biopsy despite no cancer being present. These tests should therefore be performed by a specialist, who should also determine the next steps.
If PSA blood testing and/or digital rectal examination suggest cancer, suspicion must be confirmed by biopsy (taking prostate tissue with a needle). Prostate cancer is diagnosed through one or more biopsies of the gland. Biopsy identifies benign prostatic hyperplasia, cancer or other medical problems. A needle inserted through the rectum takes several small prostate tissue samples, which are examined in a laboratory to identify any cancer cells.
If Biopsy Shows Prostate Cancer, What Should I Ask and Know First?
First, ask 2 questions:
- What stage is my prostate cancer?
- Which prostate cancer risk group am I in?
Treatment has several options: surgical removal of the prostate gland (radical prostatectomy), chemotherapy, radiotherapy and close monitoring without intervention.
The most suitable choice may be based on stage, aggressiveness or PSA values. The best approach, however, assesses all these criteria together and determines the patient's risk group (low / intermediate / high). This substantially helps both treatment decisions and following developments in prostate cancer treatment more effectively.
Close monitoring without treatment predominates in low-risk and some intermediate-risk prostate cancers; surgery and radiotherapy predominate in high-risk and other intermediate-risk cancers. Studies announcing developments constantly refer to risk groups, yet many patients do not even know their own. Before treatment, a prostate cancer patient must know their risk group, begin treatment accordingly and follow developments relevant to it.
In conclusion, learning their risk group with their physician's help is extremely important for prostate cancer patients to take a more active role in treatment decisions and following developments relating to their disease.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.